
|Videos|May 22, 2020
AAN 2020 Data Release: Ofatumumab for Relapsing MS
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Priority Review Granted for Weekly Subcutaneous Lecanemab Dosing in Early Alzheimer Disease
2
FDA Clears Pilavapadin for Phase 3 Development in Diabetic Peripheral Neuropathic Pain
3
Implications of Newborn Screening for Duchenne Muscular Dystrophy Care: Brenda L. Wong, MD; Michael Kelly, PhD
4
Managing Postpartum MS: Safety Data, Relapse Risk, and Real-World Practice
5











